High-sensitivity (HS) troponin I quantitative is a blood test that measures the precise concentration of cardiac troponin I, a protein released with heart muscle injury. It provides very low-level detection and numeric values (usually ng/L) used to diagnose acute myocardial infarction, assess cardiac risk, and monitor changes over time. Interpretation uses assay-specific, often sex-specific, cutoffs and serial measurements for rise/fall patterns.

Troponin I thresholds vary by assay, but commonly: <0.04 ng/mL is normal, 0.04–0.39 ng/mL is a borderline/elevated range suggesting possible myocardial injury, and ≥0.40 ng/mL is consistent with myocardial infarction. Actual cut-offs are assay‑specific (high‑sensitivity tests use different units), and diagnosis requires serial measurements plus symptoms, ECG and clinical assessment.

Normal high-sensitivity troponin (hs‑cTn) is below the assay-specific 99th percentile. For hs‑cTnT this is commonly <14 ng/L. Hs‑cTnI cutoffs vary by assay and sex (roughly <16 ng/L in women and <34 ng/L in men for some assays). Use your lab’s reference range and clinical context; small rises can be clinically important.

Elevated troponin indicates heart muscle injury, often from a heart attack (myocardial infarction) but also from myocarditis, pulmonary embolism, kidney failure, sepsis, or strenuous exercise. It requires urgent evaluation (ECG, imaging, repeat tests) and treatment to limit damage—reperfusion, medications, and monitoring. Higher troponin levels generally signal more extensive injury and higher risk of heart failure, arrhythmias, or death.

Yes. Severe emotional or physical stress can raise troponin by causing heart muscle injury — for example stress (Takotsubo) cardiomyopathy or demand ischemia from a catecholamine surge. Troponin also rises with myocarditis, pulmonary embolism, sepsis and other noncardiac illnesses. Any troponin elevation or chest symptoms needs prompt medical evaluation to rule out a heart attack or other serious causes.

Yes. Chronic kidney disease, especially advanced stages, can cause persistently elevated troponin I levels due to reduced clearance, myocardial strain, and frequent structural heart disease. Baseline troponin I can be higher in dialysis patients, complicating acute coronary syndrome diagnosis. Interpretation relies on clinical context and serial measurements to detect acute rises rather than single elevated values.